CoreFX anchors new European biotechnology hub in Ireland
The American nutritional science firm has officially launched its regional headquarters at the Teagasc Moorepark campus. This strategic expansion leverages Ireland's world-class research ecosystem to accelerate the development of advanced bioactive ingredients for the European market.
US-based biotechnology pioneer CoreFX Ingredients LLC has marked a triumphant expansion into Ireland, establishing CoreNhanced Biotechnology Limited as its new European headquarters. This facility, bolstered by the support of Enterprise Ireland and a strategic collaboration with Teagasc Moorepark, serves as the primary hub for the company’s scientific innovation and commercial growth across the continent. The move signifies a major vote of confidence in the Irish food science sector, providing a base for the company to refine how nutritional technologies perform throughout their lifecycle.
Minister for Enterprise, Tourism and Employment Peter Burke TD lauded the investment, noting that it reinforces Ireland’s status as a premier global destination for biotechnology and food innovation. The operation has already recruited a dedicated scientific team to spearhead applied research, while Trevor Dunne has been appointed as Managing Director of Europe to oversee the company's commercial trajectory. This leadership structure aims to bridge the gap between complex laboratory research and tangible commercial reality for European clients.
Professor Mark Fenelon, Head of the Teagasc Food Research Programme, welcomed the partnership, highlighting that the synergy between Teagasc’s research excellence and CoreFX’s industry expertise will create significant value-added opportunities. This collaboration, which has been in development since 2023, aligns with the broader national strategy to foster knowledge exchange and address shared industry challenges. Further information regarding the company's research initiatives and future developments is available on the official Enterprise Ireland website.